UBS Group
GDNA

UBS Group’s Goldman Sachs Human Evolution ETF GDNA Stock Holding History

UBS Group’s Portfolio GDNA Stock Details GDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-64
Closed -$4K – 9127
2020
Q3 		$4K Sell
64
-56
-47% -$3.56K ﹤0.01% 7489
2020
Q2 		$7K Sell
120
-250
-68% -$14.1K ﹤0.01% 7261
2020
Q1 		$18K Sell
370
-1,605
-81% -$86.1K ﹤0.01% 6572
2019
Q4 		$111K Sell
1,975
-228
-10% -$12K ﹤0.01% 5951
2019
Q3 		$108K Buy
2,203
+1,002
+83% +$50.9K ﹤0.01% 5730
2019
Q2 		$62K Buy
1,201
+1,126
+1,501% +$55.5K ﹤0.01% 5740
2019
Q1 		$4K Buy
+75
New +$3.75K ﹤0.01% 7297

UBS Group's GDNA Position: Q4 2020 in Review

UBS Group sold out of Goldman Sachs Human Evolution ETF (GDNA) in Q4 2020, closing a stake of 64 shares — an estimated $4K sold.

UBS Group first reported a position in GDNA in Q1 2019 and held it in 7 quarters. The position peaked at $111K in Q4 2019. 0 funds tracked by Wall St. Rank hold GDNA as of Q4 2020.

  • UBS Group reported no remaining Goldman Sachs Human Evolution ETF position as of Q4 2020 after selling out during the quarter.
  • UBS Group sold 64 Goldman Sachs Human Evolution ETF shares in Q4 2020, an estimated $4K.
  • UBS Group first reported a position in Goldman Sachs Human Evolution ETF in Q1 2019 and held it in 7 quarters.
  • UBS Group's Goldman Sachs Human Evolution ETF position peaked at $111K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Goldman Sachs Human Evolution ETF as of Q4 2020.

Based on UBS Group's 13F filing for Q4 2020, filed 11 Feb 2021.